EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mapping the Role of P-gp in Multidrug Resistance: Insights from Recent Structural Studies

Shi Ting Tia iD, Min Luo iD, Wenjie Fan iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26094179 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Shi Ting Tia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, National University of Singapore, Singapore 117558, Singapore. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Drug Resistance, Neoplasm, ATP Binding Cassette Transporter, Subfamily B, Member 1. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National University of Singapore Start-Up Grant, the Ministry of Education Tier 2 Grant, National Research Foundation Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

P-glycoprotein (P-gp/ABCB1), a key ATP-binding cassette (ABC) transporter, plays a central role in multidrug resistance (MDR), one of the leading causes of chemotherapy failure in cancer treatment. P-gp actively pumps chemotherapeutic agents out of cancer cells, reducing intracellular drug concentration and compromising therapeutic efficacy. Recent advancements in structural biology, particularly cryogenic electron microscopy (cryo-EM), have revealed detailed conformational states of P-gp, providing unprecedented insights into its transport mechanisms. In parallel, studies have identified various P-gp mutants in cancer patients, many of which are linked to altered drug efflux activity and resistance phenotypes. This review systematically examines recent structural studies of P-gp, correlates known patient-derived mutations to their functional consequences, and explores their impact on MDR. We propose plausible mechanisms by which these mutations affect P-gp’s activity based on structural evidence and discuss their implications for chemotherapy resistance. Additionally, we review current approaches for P-gp inhibition, a critical strategy to restore drug sensitivity in resistant cancers, and outline future research directions to combat P-gp-mediated MDR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, MultipleDrug Resistance, NeoplasmATP Binding Cassette Transporter, Subfamily B, Member 1HumansMutationNeoplasmsAnimalsAntineoplastic AgentsProtein ConformationATP Binding Cassette Transporter, Subfamily B

Stichwörter der Autor:innen

ABC transportercancercryo-electron microscopymultidrug resistance

Substanzen

ATP Binding Cassette Transporter, Subfamily B, Member 1Antineoplastic AgentsATP Binding Cassette Transporter, Subfamily B

Autor:innen und Institutionen

  • Department of Biological Sciences, National University of Singapore, Singapore 117558, Singapore.
  • Center for Bioimaging Sciences, Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.

ORCID-Profile: Shi Ting Tia, Min Luo, Wenjie Fan

Förderung

  • National University of Singapore Start-Up Grant, the Ministry of Education Tier 2 Grant
  • National Research Foundation Grant

Zitieren

APA

Tia, S. T., Luo, M., & Fan, W. (2025). Mapping the Role of P-gp in Multidrug Resistance: Insights from Recent Structural Studies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094179

Vancouver

Tia ST, Luo M, Fan W. Mapping the Role of P-gp in Multidrug Resistance: Insights from Recent Structural Studies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094179

BibTeX
@article{Tia2025,
  author = {Tia, Shi Ting and Luo, Min and Fan, Wenjie},
  title = {Mapping the Role of P-gp in Multidrug Resistance: Insights from Recent Structural Studies},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26094179}
}
Kostenlos starten →